Jiangsu Nhwa Pharmaceutical Hits Day Low Amid Price Pressure at CNY 20.89

Jiangsu Nhwa Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 4.88% on March 23, 2026. The stock reached an intraday low of CNY 20.89, reflecting ongoing challenges in its market performance. Over the past week, the stock has seen a decrease of 7.35%, and its performance over the last month shows a decline of 11.18%. In comparison, the China Shanghai Composite index has also faced downward pressure, declining by 3.63% today and 6.65% over the past week. Year-to-date, Jiangsu Nhwa has underperformed with a drop of 12.76%, contrasting sharply with the broader market's decline of 3.92%. Despite a five-year performance increase of 41.94%, the company has struggled in recent years, with a return of -12.11% over the last three years. Key financial metrics indicate a return on equity of 15.16% and a price-to-book ratio of 2.58, suggesting a fair valuation amidst the current market conditions. The company maintains a dividend yield of 1.51%, providing some return to shareholders despite the recent stock performance.